Nang Kuang Pharmaceutical Co., Ltd.

NT$29.80As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1752Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 1.11%
Div yield 5.37%
ROE 8.50%
Medical Instruments & Supplies
Beta (5Y) 0.16
PE TTM 14.68
TSR TTM (19.29%)
Mkt cap NT$3.009B
ROIC 8.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$37
25.68%
6.07%
Hold 11|8|12|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.72
0.69
0.68
0.73
37.90%
19.32%
8.13%
4.99%
RevenueNT$M
175.4
172.6
177.3
185.7
7.26%
(0.08%)
3.99%
2.77%
Peers (US$90.89M)
Cap (US$)
PE
107.4M
38.25x
106.3M
24.77x
94.01M
10.78x
Capital
TTM
5Y
10Y
Leveragex
0.878
0.195
0.132
EBIT/Intx
0.938
0.511
0.505
Own earn%
(23.46)
(25.85)
(28.30)
Sh yield%
50.57
51.20
50.66
Owners
Insiders/Inst%
4.81
50.56
Short interest%
4.46
SBC / revenue%
2.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
21–34
$1 testx
—
Incr. ROIC%
2